Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and Metabolic...

Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes andMetabolic SyndromeJapanese and Other Ethnic Minorities at Increased Risk

BALTIMORE, April 4, 2008 /PRNewswire/ -- Newly published data by Dr. J.Barthelow Classen in The Open Endocrinology Journal shows a 50% reduction oftype 2 diabetes occurred in Japanese children following the discontinuation ofa single vaccine, a vaccine to prevent tuberculosis. This decline occurred ata time when there is a global epidemic of type 2 diabetes and metabolicsyndrome, which includes obesity, altered blood cholesterol levels, high bloodpressure, and increased blood glucose resulting from insulin resistance.

Classen proposes a new explanation for the epidemic of both insulindependent diabetes (type 1 diabetes), which has previously been shown to becaused by vaccines and non insulin dependent diabetes (type 2 diabetes). Uponreceipt of vaccines or other strong immune stimulants some individuals developa hyperactive immune system leading to autoimmune destruction of insulinsecreting cells. Other individuals produce increased cortisol, an immunesuppressing hormone, to suppress the vaccine induced inflammation. Theincreased cortisol leads to type 2 diabetes and metabolic syndrome. Japanesechildren have increased cortisol secretion following immunization compared toWhite children and this explains why Japanese have a relative high rate oftype 2 diabetes but low rate of insulin dependent diabetes compared to Whites.

The lower cortisol response attributed to type 1 diabetes and the highercortisol response attributed to type 2 diabetes explains why type 1 diabeticsare generally leaner than type 2 diabetics since elevated cortisol causesweight gain.

"The current data shows that vaccines are much more dangerous than thepublic is lead to believe and adequate testing has never been performed evenin healthy subjects to indicate that there is an overall improvement in healthfrom immunization. The current practice of vaccinating diabetics as well astheir close family members is a very risky practice," says Dr. J. Barthelow Classen.

Classen's research has become widely accepted. To view the publishedpapers and to find out the latest information on the effects of vaccines onautoimmune diseases including insulin dependent diabetes visit the VaccineSafety Web site www.vaccines.net/newpage11.htm

Classen Immunotherapies, Inc.
6517 Montrose Avenue
Baltimore, MD 21212 U.S.A.
Tel: (410) 377-8526
Classen@vaccines.net
vaccines.net

SOURCE Classen Immunotherapies, Inc.
Classen Immunotherapies, Inc., +1-410-377-8526, Classen@vaccines.net